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Abstract
Studies conducted in China linked selenium deficiency to higher risk of esophageal 
squamous cell carcinoma (ESCC), but this has not been widely tested outside 
that selenium- deficient region. The aim of this study was to investigate the as-
sociation between selenium and other mineral concentrations in toenails and risk 
of ESCC in a region with high incidence rates. In this nested case–control study, 
we identified 222 cases of ESCC from the Golestan Cohort Study, Iran, which 
has followed up 50,045 participants since enrollment (2004–2008). We randomly 
selected one control for each case matched by age and sex, using incidence density 
sampling. We used toenail samples collected at baseline to measure the concen-
tration of selenium, zinc, chromium, mercury, and scandium using instrumental 
neutron activation analysis. Multivariate adjusted logistic regression models were 
used to estimate odds ratios (OR) and 95% confidence intervals. Median nail 
selenium, zinc, chromium, and mercury levels were 1.01, 74.59, 0.77, and 0.018 μg/g 
in cases and 1.02, 75.71, 0.71, and 0.023 μg/g in controls, respectively. The ad-
justed odds ratios comparing each fourth quartile of mineral status versus the 
first quartile were as follows: selenium = 0.78 (95% CI, 0.41–1.49); zinc=0.80 
(95% CI, 0.42–1.53); chromium = 0.91 (95% CI, 0.46–1.80); and mercury=0.61 
(95% CI, 0.27–1.38), and all trend tests were non–significant. The nail selenium 
concentration in our controls reflects relatively high selenium status. No evidence 
of association between selenium or chromium concentrations in toenails and the 
risk of ESCC was detected in this population.
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Introduction
Esophageal cancer is the sixth most common cause of 
cancer death in the world. The most divergence in cancer 
incidence worldwide is seen in esophageal cancer [1], 
pointing to the possible role of environmental factors in 
the development of this cancer.
Golestan Province in northeastern Iran is one of the high 
incidence areas for esophageal cancer, and 90% of the cases 
are esophageal squamous cell carcinoma (ESCC) [2], which 
is the most common type of esophageal cancer in the world 
[3]. Ecological studies have reported that selenium concen-
tration is significantly higher and zinc concentration is 
significantly lower in the soil of high- risk regions than in 
low- risk regions across Golestan province [4–7]. However, 
studies conducted in central China linked selenium and 
zinc deficiency to higher risk of ESCC [8, 9].
Selenium is a cofactor of the glutathione peroxidase 
enzymes, and protects cells against oxidative stress. 
Moreover, some selenium compounds are antiproliferative 
and proapoptotic agents and have other anticarcinogenic 
properties [10]. Selenium may prevent cancer by prevent-
ing mutation, and decreasing DNA damage via P53 [11]. 
Zinc also has antioxidant and proapoptotic properties, 
and, as a cofactor of metalloenzymes, affects regulation, 
transcription, and replication of DNA [12, 13]. Some 
compounds of chromium and mercury are suspected to 
be carcinogens [14–16]. Exposure of animals to chromium 
in drinking water induced alimentary tract cancer in mice 
[14].
In a previous study from Golestan Province, we found 
an inverse association between dietary zinc intake and a 
U- shaped association between selenium intake (assessed 
via food frequency questionnaire) and ESCC risk [17]. 
However, estimating average dietary mineral intake using 
available food composition data is not always accurate, 
because the bioavailability of minerals varies with the 
intake of other dietary components, such as phytate, in 
the food matrices which can influence their absorption 
[18] Therefore, the use of biomarkers such as toenails 
may provide a better estimate of mineral status compared 
with estimates based on questionnaires in modeling the 
role of these minerals in ESCC risk [19–21].
Despite some evidence regarding a possible role for 
selenium and zinc in ESCC in one high- risk area of China, 
this has not been tested outside this one selenium- deficient 
region, and the association between chromium or mercury 
and risk of ESCC has never been investigated, using a 
reliable biomarker in a prospective study. The aim of 
this study was, therefore, to investigate the association 
between prediagnostic toenail concentrations of minerals 
and the risk of ESCC in a population with high risk of 
this cancer.
Methods
Subjects and study design
The design of the Golestan Cohort Study has been described 
previously [22]. In this cohort study, 50,045 subjects 
45 years and older were enrolled between 2004 and 2008 
from the eastern three districts of Golestan Province: 
Gonbad (both urban and rural), Kalaleh (rural), and Aq 
Qala (rural). The participants provided demographic and 
dietary data (by a validated food- frequency- questionnaire), 
and provided biospecimens including toenails.
All subjects provided written informed consent before 
enrollment, and the study was approved by the Institutional 
Review Boards of the Digestive Disease Research Institute 
(DDRI) of Tehran University of Medical Sciences and 
the US National Cancer Institute.
Subjects in the Golestan Cohort Study were followed 
up for cancer and other major outcomes [22]. Participants 
were asked to contact the cohort team after any new 
disease diagnosis or hospitalization. Also, subjects were 
interviewed by phone annually and a short health ques-
tionnaire was administered. Each report of cancer diagnosis 
was followed by a home or medical center visit. The 
cohort team collected all clinical reports, hospital records, 
tumor samples, and pathology reports which were avail-
able. Any report of pathology was confirmed by an Endpoint 
Review Committee. The cohort subject list was also checked 
against the Golestan Population- based Cancer Registry 
(GPCR), which covers all Golestan Province and is one 
of the high- quality registries included in Cancer Incidence 
in Five Continents [22]. Loss to follow- up in the cohort 
is negligible (<1%).
For each case, a control was selected randomly via 
incidence density sampling without replacement [23]. 
Eligible controls were free of esophageal or other digestive 
tract cancers at the time of case diagnosis, and were risk- 
set matched to cases individually on age (within 2 calendar 
years) and sex.
Mineral concentration measurements
During the baseline enrollment examination, subjects were 
asked to provide a toenail sample. Nail specimens were 
placed in labeled plastic bags and stored at room tem-
perature. Toenails were provided by 99.9% of 
participants.
The concentrations of selenium, zinc, chromium, and 
mercury were measured by instrumental neutron activa-
tion analysis (INAA) at the University of the Missouri 
Research Reactor. Details of the method, which has been 
used for selenium and other minerals, has been published 
before [21].
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For quality control, the samples were coanalyzed with 
NIST SRM 1577 Bovine Liver, NIST SRM 1571 Orchard 
Leaves, and NCS DC 73347 Hair. The measured values 
of selenium, chromium, zinc, and mercury in these sam-
ples agreed well with the accepted values.
Concentrations of scandium and aluminum in toenails 
were also measured because they are understood to reflect 
terrestrial material, soil, or dust that is adherent to the 
nail. Selenium, zinc, and mercury were not correlated 
with these terrestrial indicators, but chromium was cor-
related with the concentrations of scandium and aluminum. 
Therefore, we used the residual method and regressed 
the concentration of chromium on the concentration of 
scandium, added back the mean and used this residually 
adjusted value. Given the need to perform this procedure 
to decrease the potential effect of terrestrial contamina-
tion, the results of the chromium analysis should be 
interpreted with caution.
Two hundred and twenty- nine toenail samples had suf-
ficient mass to allow preparation of a duplicate sample for 
analysis. The mean difference between duplicate samples did 
not differ significantly from zero. The coefficients of varia-
tion for duplicate samples were 2.3% for selenium, 4.1% 
for zinc, 17.1% for chromium, and 27% for mercury.
Statistical analysis
Baseline demographic data for ESCC cases and controls 
were compared using chi- square tests for categorical vari-
ables and Kruskal–Wallis tests for continuous variables. 
Partial correlations were used to assess the predictors of 
nail element concentrations.
Associations between toenail minerals and risk of ESCC 
were examined using multivariate- adjusted logistic regres-
sion. Since we matched individually on age and sex, we 
initially used conditional regression models. However, we 
observed associations between selenium and mercury con-
centrations and district of residence. Since the participants 
of our study were from Gonbad (urban, n = 97, and 
rural, n = 169), Kalaleh (only rural, n = 166), and Aq 
Qala (only rural, n = 11), we made a composite variable 
for place of residence using district and rural/urban status 
and created four categories: Gonbad rural, Gonbad urban, 
Kalaleh, and Aq Qala. For the logistic regression model 
results, which are presented, we broke the matching to 
allow better control for confounding by place of residence 
and used unconditional logistic regression for analysis. 
All models included the matching factors (age and sex) 
and the composite place of residence variable. The results 
of the conditional logistic regression models did not differ 
meaningfully from those of the unconditional logistic 
regression models, but the unconditional models provided 
better precision.
Mineral concentrations were divided into quartiles using 
nail concentrations among controls, and median values of 
each quartile were used to test for trend. For the logistic 
regression models, we scaled the continuous metrics of the 
mineral concentrations to one half of the interquartile range 
among controls ((75th percentile- 25th percentile)/2), which 
is easier to compare to the step- wise differences between 
quartiles. The continuous ORs should be interpreted as 
increase of 0.11 μg/g for selenium, 11.15 μg/g for zinc, 
0.40 μg/g for chromium, and 0.01 μg/g for mercury.
Suspected confounders were tested in the unconditional 
logistic regression models including age, sex, place of 
residence (Gonbad rural, Gonbad urban, Kalaleh, and Aq 
Qala), smoking (pack- years), opium use (ever, never), 
socioeconomic status (determined by a composite score) 
[24], formal education (none, any), ethnicity (non- 
Turkmen, Turkmen), body mass index (BMI) (<18.5, 18.5 
to <25, 25 to <30, ≥30), family history of esophageal or 
gastric cancer in first- degree relatives (yes, no), physical 
activity level at work (irregular nonintense, regular non-
intense, irregular intense, or regular intense) [17], and 
the daily intake of fruits and vegetables (grams/day). Since 
alcohol is not a risk factor in this region due to the very 
low prevalence of alcohol use (4 percent) [25], we did 
not adjust for drinking alcohol.
Interactions were investigated by multiplying each min-
eral concentration by each potential effect modifier and 
the resulting models were tested using the likelihood ratio 
test. In sensitivity analyses, we excluded subjects with BMI 
less than 18.5 or more than 35 kg/m2. We stratified our 
analysis by the follow- up time (time from enrollment to 
diagnosis: ≤2 years, >2–5 years, and > 5 years). Potential 
nonlinear associations between each mineral concentration 
and risk of ESCC were evaluated using restricted spline 
models. The data were analyzed using STATA software 
(version 13, STATA Corp, College Station, TX). All tests 
of statistical significance were two- sided and p- values <0.05 
were considered statistically significant.
Results
Subjects characteristics
At the time of selection, there were 222 eligible ESCC 
cases and 222 controls in the study, but a single case 
did not provide a toenail sample. Baseline characteristics 
for the remaining 221 ESCC cases and 222 controls are 
shown in Table 1.
Mineral concentrations
The median and interquartile range of nail concentration 
of each mineral are shown in Table 1. The concentration 
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of selenium and zinc did not differ significantly between 
cases and controls. Incident ESCC cases had lower baseline 
nail concentrations of mercury and higher concentrations 
of chromium (Table 1).
Partial correlations were used to investigate the associa-
tion between the concentration of each mineral and each 
suspected risk factor or other minerals. The percent of 
squared partial correlations of minerals have been shown 
in Table S1.
The concentration of selenium in nails was different 
in each place of residence (P = 0.008). The median (inter-
quartile range) nail concentration in Gonbad rural was 
1.056 (0.901–1.174) μg/g, in Gonbad urban was 1.019 
(0.947–1.128), in Kalaleh was 1.004 (0.897–1.130) μg/g, 
and in Aq Qala was 0.920 (0.797–1.044) μg/g.
Mineral concentrations and cancer risk
In the fully adjusted quartile analyses, there were no sta-
tistically significant differences in any of the mineral con-
centrations by case status (Table 2). In the fully adjusted 
continuous analyses, the concentrations of selenium, zinc, 
and chromium were not associated with case status, but 
the mercury concentration was inversely associated with 
risk of ESCC (HR = 0.88, 95% CI = 0.79–0.99). Further 
adjustment by usual consumption of fish had little effect 
on the point estimate for mercury, but did make the 
association nonsignificant (HR = 0.89, 95% CI = 0.79–
1.00, P = 0.052). Adjustment for nail mass and year or 
season of nail collection did not change the point 
estimates.
There was no interaction between mineral content and 
gender, age, education, place of residence, or ethnicity 
and risk of ESCC. We excluded subjects with BMI less 
than 18.5 or more than 35 kg/m2, because the mean BMI 
was significantly lower in case subjects, but the results 
did not change significantly. Stratifying by follow- up time, 
the adjusted hazard ratios for zinc was 0.26 (95% 
CI = 0.07–0.97), and for chromium was 0.22 (95% 
CI = 0.05–0.96), for ESCC cases diagnosed more than 
5 years after enrollment (Table S2).
Lastly, we explored the possibility of a nonlinear rela-
tionship between each mineral and risk of ESCC using 
restricted cubic splines, however we found no evidence 
Table 1. Baseline characteristics of esophageal squamous cell carcinoma case and control participants in the golestan cohort study
ESCC Case subjects (N = 221) Control subjects (N = 222) P value
Age, years 1 60.2 ± 9.3 59.1 ± 9.3 0.23
Male 2 120 (54.3) 120 (54.1) 0.96
BMI1, kg/m2 23.1 ± 4.4 26.8 ± 6.1 <0.001
Smoking, pack- year1 5.7 ± 19.6 2.9 ± 9.1 0.30
SES2 <0.001
Low 106 (48.0) 60 (27.0)
Low- Medium 54 (24.4) 55 (24.8)
Medium- High 41 (18.5) 58 (26.1)
High 20 (9.0) 49 (22.1)
Family history, positive2 55 (24.9) 43 (19.3) 0.16
Place of residence 2 <0.001
Gonbad urban 17 (7.7) 81 (36.5)
Gonbad rural 97 (43.9) 71 (32.0)
Kalaleh 98 (44.3) 68 (30.6)
Aq Qala 9 (4.1) 2 (0.9)
Ethnicity, Turkmen2 182 (82.3) 167 (75.2) 0.07
Opium use2 57 (25.8) 37 (16.7) 0.02
No formal education2 186 (84.1) 161 (72.52) 0.003
Physical activity 0.03
Irregular, nonintense 154 (69.7) 126 (56.8)
Regular, nonintense 48 (21.7) 65 (29.3)
Irregular or regular, intense 19 (8.6) 30 (13.5)
Fruit intake, grams/day1 143.3 ± 168.4 168.7 ± 123.0 <0.001
Vegetable intake, grams/day1 176.5 ± 87.3 201.4 ± 101.9 0.02
Baseline nail mineral levels (μg/g), median (interquartile range)
Selenium 1.009 (0.89–1.13) 1.020 (0.92–1.14) 0.18
Zinc 74.59 (62.60–83.67) 75.71 (63.71–86.89) 0.22
Chromium 0.77 (0.47–1.44) 0.71 (0.42–1.13) 0.007
Mercury 0.018 (0.01–0.03) 0.023 (0.01–0.05) 0.002
1Mean ± SD.
2Percent.
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of such a relationship (P- values for a nonlinear associa-
tion were: selenium = 0.58, zinc = 0.90, chromium = 0.50, 
and mercury = 0.13).
Discussion
In our case–control study nested within the Golestan 
Cohort, selenium and chromium nail concentrations were 
not significantly associated with risk of ESCC. There was 
no effect modification of BMI, ethnicity, education, opium, 
or smoking in the results.
Mark et al., showed an inverse association between 
serum selenium levels and risk of ESCC in the Nutrition 
Intervention Trial (NIT) cohort in a selenium- deficient 
area in China [8]. In another previous study, Steevens 
et al., showed an inverse association between toenail sele-
nium concentrations and the risk of ESCC in the Netherland 
Cohort Study [26]. However, the median toenail selenium 
was 0.55 μg/g in the Dutch population, compared with 
1.01 μg/g in Golestan. Thus, the lack of association in 
our study may be related to the fact that very few indi-
viduals in our study were selenium- deficient. In a previous 
study of dietary selenium, we found a statistically significant 
nonlinear U- shaped association between selenium intake 
and the risk of ESCC in the Golestan Cohort population 
[17]. However, selenium intake did not correlate with 
toenail measurements in our study (r = 0.02). Similar 
discrepancies have been reported in other studies. In the 
ORDET study, toenail and dietary selenium were not cor-
related, (r = 0.02; P = 0.72) [27], and in Ovaskainen 
et al., they were weakly correlated (r = 0.18, P ≤ 0.05) 
[28]. Longnecker et al., reported the concentration of 
selenium in a single specimen of whole blood, serum, or 
toenails served reasonably well as a measure for ranking 
subjects according to long- term selenium intake but pro-
vided only a rough estimate of intake for each subject 
[29]. We acknowledge the potential for residual confound-
ing from other (unmeasured) dietary components which 
are correlated with selenium intake. There might be dif-
ferences in metabolism in different subjects.
An ecologic study in Golestan Province by Keshavarzi 
et al. reported that the selenium concentrations in soil, 
grain, and drinking water increase from the low- risk area 
to the high- risk area for ESCC [4]. The relative concentra-
tions of selenium in nails that we measured (nail concen-
tration in Gonbad = 1.034 μg/g, and in Kalaleh=1.004 μg/g) 
were compatible with the relative concentrations of selenium 
in soil in the Keshavarzi et al. study (soil concentration 
in Gonbad = 1.22 μg/g, and in Kalaleh = 0.77 μg/g). In 
another ecologic study, the median serum selenium level 
in subjects who live in Golestan Province was higher than 
that in other low- risk areas for esophageal cancer in Iran 
[7]. The selenium intake among cohort participants in 
Golestan was greater than the US RDA (55 μg/day) in our 
previous study [17]. Nail selenium concentrations among 
controls in our study were high in comparison with 
Table 2. Associations of nail mineral concentrations and esophageal squamous cell carcinoma in the Golestan Cohort Study
Quartile analysis Continuous analysis1
Q1 Q2 Q3 Q4 P for trend P
Selenium
Cases 70 45 54 52
OR2 (95% CI) 1 0.65 (0.39–1.11) 0.77 (0.46–1.29) 0.76 (0.45–1.27) 0.38 0.94 (0.84–1.06) 0.35
OR3 (95% CI) 1 0.90 (0.48–1.69) 0.92 (0.49 –1.74) 0.78 (0.41–1.49) 0.48 0.94 (0.80–1.09) 0.40
Zinc
Cases 64 55 55 47
OR2 (95% CI) 1 0.87 (0.52–1.47) 0.86 (0.51–1.44) 0.75 (0.44–1.27) 0.29 0.92 (0.82–1.03) 0.13
OR3 (95% CI) 1 0.75 (041–1.37) 0.90 (0.49–1.67) 0.80 (0.42–1.53) 0.62 0.96 (0.83–1.10) 0.54
Chromium
Cases 45 55 50 71
OR2(95% CI) 1 1.24 (0.72–2.14) 1.11 (0.64–1.92) 1.61 (0.95–2.72) 0.09 1.1 (1.01–1.20) 0.04
OR3 (95% CI) 1 0.88 (0.44–1.76) 0.63 (0.31–1.25) 0.91 (0.46–1.80) 0.97 1.03 (0.93–1.13) 0.60
Mercury
Cases 69 63 66 23
OR2 (95% CI) 1 0.93 (0.56–1.54) 0.97 (0.59–1.61) 0.33 (0.18–0.61) <0.001 0.84 (0.77–0.92) 0.000
OR3 (95% CI) 1 0.95 (0.53–1.70) 1.59 (0.87–2.91) 0.61 (0.27–1.38) 0.29 0.88 (0.79–0.99) 0.03
1should be interpreted as increase of 0.11 μg/g for selenium, 11.15 μg/g for zinc, 0.40 μg/g for chromium, and 0.01 μg/g for mercury. 
2Crude model.
3Adjusted for age (years), sex (M, F), place of residence (Gonbad urban, Gonbad rural, Kalaleh, Aq Qala), smoking (pack- years), socioeconomic status 
(low, low- medium, medium- high, high), ethnicity (non- Turkmen, Turkmen), opiate use (never, ever), body mass index (<18.5, 18.5 to <25, 25 to <30, 
>=30), education (no formal, formal education), physical activity (irregular nonintense, regular nonintense, irregular or regular intense), family history 
(positive, negative), fruit intake (g/d), and vegetable intake (g/d); ORs (95% CI) were calculated using an unconditional logistic regression models.
3057© 2017 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. 
Toenail Mineral Concentration and EsophagealM. Hashemian et al.
previous studies which targeted other diseases in other 
population (Table 3) [26–31]. Our findings suggest that 
selenium deficiency is not a risk factor for the high inci-
dence of ESCC in northeastern part of Iran.
Our previous analysis of dietary intake of zinc in this 
population showed an inverse association between zinc 
intake and risk of ESCC [17]. The difference in the results 
of this previous dietary intake analysis and the current 
analysis of nail concentrations could be due to different 
metabolism of zinc in different subjects, or to the con-
founding effect of other (unmeasured) agents which are 
correlated with intake of zinc. Keshavarzi et al. found 
that total zinc concentrations in soil and grain samples 
decreased from low- to high- risk areas for ESCC in Golestan 
[4], and Abnet et al., found an inverse association between 
tissue zinc concentrations in normal esophageal tissue and 
risk of ESCC in a prospective study in China [9]. We 
also found an inverse association between nail zinc con-
centration and ESCC in subjects who were followed more 
than 5 years. This results could be due to sparse data or 
may reflect that zinc concentrations could have been due 
to reverse causation. We are not aware of any previous 
prospective study which has investigated the association 
between toenail zinc status and ESCC [32]. Nouri et al., 
showed that the nail zinc concentration was lower in 20 
cases than 80 controls in a case–control study [33], and 
in the NIT intervention trial in China, the group that 
received oral zinc and retinol supplements experienced 
no reduction in ESCC risk [34].
This study is the first to evaluate the effect of mercury 
and chromium on risk of ESCC. Some compounds of 
these two minerals are suspected to be carcinogens [14–16]. 
Chromium may cause mutations and chromosomal breaks 
and exposure of animals to chromium in drinking water 
can induce alimentary tract cancer in mice [14]. Our 
results showed no association between nail chromium 
concentrations and ESCC risk. Few other studies have 
measured chromium in toenails. The concentration of 
chromium in our study (0.71 μg/g) was more than that 
reported in the FINBAR study conducted in Ireland 
(0.55 μg/g) [35]. Surprisingly, we also found an inverse 
association between toenail chromium concentration and 
risk of ESCC. The number of cases in this analysis was 
small. We are not aware of any study to support a pro-
tective association with chromium and we therefore con-
clude that this a chance finding.
Methylmercury compounds have been reported to be 
associated with lung, brain, and prostate cancer [15]. In 
this study, although the highest quartile of toenail mercury 
was not associated with risk of ESCC, increasing toenail 
mercury concentration as a continuous variable was 
inversely associated with ESCC. This inverse association 
may reflect the protective effect of fish consumption (the 
primary dietary source of mercury). After adjusting the 
model for fish consumption, the association remained 
protective, but was no longer statistically significant. We 
caution that the observed association is based on small 
case numbers. Also of note, the mean concentration of 
mercury among controls in this study was very low 
(0.04 ± 0.05 μg/g) compared to those reported in the 
Nurse’s Health Study (0.33 ± 0.63 μg/g) and the Health 
Professionals Follow- up Study (excluding dentists) 
(0.44 ± 0.47 μg/g) in the US [36] and the FINBAR case- 
control study (0.11 ± 0.23 μg/g) in Ireland [35].
One of the strengths of this study is that toenails were 
collected at the beginning of the cohort study, so the 
mineral concentrations are prediagnostic, and 99% of the 
cohort population provided nail samples. Toenail 
Table 3. Selenium concentrations of toenail samples among controls in previous studies
The place of the Study The name of the Study
Median nail selenium  
concentrations (μg/g)
Mean nail selenium  
concentrations (μg/g)
Iran (current study) GCS1 1.02 (0.92–1.14)
US, MD [30] CLUE II2 0.79 (0.70–0.87)
US [30] HPFS3 0.80 (0.73–0.94)
Netherlands [26] NLCS4 0.55 (0.48–0.60)
US [30] SELECT5 0.88 (0.77–0.99)
Italy [27] ORDET6 0.96
China [31] 0.47 (range=008–4.22)
Finland [28] 0.47 ± 0.09
1GCS = Golestan Cohort Study.
2CLUE II = Campaign against Cancer and Stroke.
3HPFS = Health Professionals Follow- up Study.
4NLCS = Netherlands Cohort Study.
5SELECT = Selenium and Vitamin E Cancer Prevention Trial.
6Hormones and Diet in the Etiology of Breast Cancer.
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measurements are believed to represent a marker of expo-
sure during last year prior to clipping. A limitation of 
our study is that soil levels of selenium differ across the 
region and having a larger number of cases across the 
different regions would allow us more power to look at 
the association in high and low selenium regions. We 
collected nail samples at baseline which reflect the mineral 
status at baseline of the study, we were not able to inves-
tigate the changes in diet during the follow- up. We suggest 
that future studies evaluate the changes in element con-
centrations in nail samples over time.
In summary, this study in a high- risk area of ESCC, 
showed no evidence of association between toenail sele-
nium, or chromium and risk of ESCC.
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